View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Contact Clinical Care Options
For customer support please email: customersupport@clinicaloptions.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Video from Clinical Care Options (CCO): metabolic adaptations in obesity, value of sustained weight loss, and latest evidence for incretin-based therapies: semaglutide, tirzepatide, and mores
Randy J. Seeley, PhD
Jenny Tong, MD, MPH
Kristina M. Utzschneider, MD
Physicians:
maximum of 1.5 AMA PRA Category 1 Credits™
Registered Nurses:
1.5 Nursing contact hours
Pharmacists:
1.5 contact hours (0.15 CEUs)
Released: July 26, 2021
Expired:
July 25, 2022
Clinical Care Options (CCO) presents Dr. George L. Bakris answering common questions about renoprotection strategies in CKD in T2D
George Bakris, MD
Released: July 23, 2021
Practicing Clinicians Exchange presents Fatima Cody Stanford, MD, MPH, MPA, MBA, answering commonly asked questions about the use of GLP-1 receptor agonist pharmacotherapy in obesity management.
Fatima Cody Stanford, MD, MPH, MPA, MBA
Released: July 22, 2021
Learn about renoprotection in diabetic kidney disease, CKD and CV outcomes; focus on emerging MR antagonists, from Clinical Care Options (CCO)
George Bakris, MD
Vivian A. Fonseca, MD, FRCP
Susanne Nicholas, MD, MPH, PhD
Released: June 22, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.